GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Windlas Biotech Ltd (NSE:WINDLAS) » Definitions » FCF Yield %

Windlas Biotech (NSE:WINDLAS) FCF Yield % : 5.42 (As of Jun. 04, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Windlas Biotech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Windlas Biotech's Trailing 12-Month Free Cash Flow is ₹713 Mil, and Market Cap is ₹13,138 Mil. Therefore, Windlas Biotech's FCF Yield % for today is 5.42%.

The historical rank and industry rank for Windlas Biotech's FCF Yield % or its related term are showing as below:

NSE:WINDLAS' s FCF Yield % Range Over the Past 10 Years
Min: -1.49   Med: 0   Max: 5.59
Current: 5.42


During the past 6 years, the highest FCF Yield % of Windlas Biotech was 5.59%. The lowest was -1.49%. And the median was 0.00%.

NSE:WINDLAS's FCF Yield % is ranked better than
79.48% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.195 vs NSE:WINDLAS: 5.42

Windlas Biotech's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Windlas Biotech FCF Yield % Historical Data

The historical data trend for Windlas Biotech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Windlas Biotech FCF Yield % Chart

Windlas Biotech Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Yield %
Get a 7-Day Free Trial - - -1.24 -2.11 6.72

Windlas Biotech Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Windlas Biotech's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Windlas Biotech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Windlas Biotech's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Windlas Biotech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Windlas Biotech's FCF Yield % falls into.



Windlas Biotech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Windlas Biotech's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=712.76 / 10613.52558
=6.72%

Windlas Biotech's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 10613.52558
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Windlas Biotech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Windlas Biotech FCF Yield % Related Terms

Thank you for viewing the detailed overview of Windlas Biotech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Windlas Biotech (NSE:WINDLAS) Business Description

Traded in Other Exchanges
Address
Golf Course Extension Road, 705-706, Vatika Professional Point, Sector-66, Gurgaon, HR, IND, 122 001
Windlas Biotech Ltd is a pharmaceutical formulations contract development and manufacturing organization. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.

Windlas Biotech (NSE:WINDLAS) Headlines

No Headlines